Study to Evaluate the Effect of RGMA001 on Patients With Non Alcoholic Fatty Liver Disease (NAFLD)

NCT01511523 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Alcoholic Fatty Liver Disease

Interventions

DIETARY_SUPPLEMENT: RGMA001
DIETARY_SUPPLEMENT: Sugar Pill

Sponsor

Biovil Research Group, LLC